Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

Joseph Kuo(Scripps Research Institute), Philippe Gallay(Scripps Research Institute), Magnus J. Hansson(Medicon Village), Alvar Grönberg(NeuroVive Pharmaceutical (Sweden)), Sonia Serrano, Ramin Massoumi(Lund University)
Frontiers in Pharmacology
September 26, 2019
Cited by 20


Related Papers